Kickstarter sent an email to all users Saturday saying that hackers had made off with user data in the security breach. Two users accounts were compromised, Kickstarter said in an update on its website.
No credit card data was obtained in the attack, which began Wednesday night. The hackers were able to obtain access to usernames, email addresses, mailing addresses, phone numbers and encrypted passwords.
"Actual passwords were not revealed, however it is possible for a malicious person with enough computing power to guess and crack an encrypted password, particularly a weak or obvious one," the Kickstarter site said in a blog post. "As a precaution, we strongly recommend that you create a new password for your Kickstarter account, and other accounts where you use this password," the blog added.
Top 5 European Companies To Own In Right Now: Central Securities Corp (CET)
Central Securities Corporation is a non-diversified, closed-end management investment company. The Company�� primary investment objective is growth of capital. Central Securities Corporation invests primarily in common stocks, but it may invest in bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks and corporations.
The Company, from time to time, invests in securities, the resale of which is restricted. Central Securities Corporation invests in various sectors, including insurance, Semiconductor, Technology Hardware and Equipment, Diversified Industrial, Energy, Software and Services, Banking and Finance and other.
Advisors' Opinion:- [By Joe Eqcome]
Actionable Items:
Highest Positive Spread: ING Emerging Markets High Dividend Equity Fund (IHD)Focus Stock: Central Securities Corporation (CET)Last Week's Focus Stock: Central Securities CorporationJunk Bonds Debacle: The $85 billion monthly bond-purchase program has produced a selloff for "junk" bonds. The U.S. Treasurys jumped 0.18% to 4.39% on Wednesday. The benchmark 10-Year Treasury note has risen 0.5% in the past month.
Top 10 US Companies To Buy Right Now: Allergan Inc. (AGN)
Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment offers a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma therapy, ocular inflammation, infection, allergy, and retinal diseases; Botox for the therapeutic and aesthetic indications; skin care products for acne, psoriasis, and other skin care products; eyelash growth products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products, including the La p-Band System and the Orbera Intragastric Balloon System; and facial aesthetics products. The company also offers Contigen for the treatment of urinary incontinence due to intrinsic sphincter deficiency. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. Allergan, Inc. has strategic research collaboration agreements with ExonHit Therapeutics S.A.; Spectrum Pharmaceuticals, Inc.; and Pieris AG. The company was founded in 1948 and is headquartered in Irvine, California.
Advisors' Opinion:- [By Ben Levisohn]
Yesterday, shares of Actavis (ACT) gained 1.7% after it said it would pay $66 billion to buy Allergan (AGN). With another day to mull the news, shares have pushed shares of Actavis up more than 8%.
- [By Garrett Cook]
Salix Pharmaceuticals (NASDAQ: SLXP) shares shot up 5.52 percent to $168.66 on report of takeover talks with Allergan. Allergan (NYSE: AGN) is set to acquire Salix Pharmaceuticals in a deal probably worth more than $10 billion, according to Dow Jones Newswires.
- [By Jake L'Ecuyer]
Leading and Lagging Sectors
In trading on Tuesday, healthcare shares were relative leaders, up on the day by about 1.50 percent. Meanwhile, top gainers in the sector included Allergan (NYSE: AGN), up 15.7 percent, and Idera Pharmaceuticals (NASDAQ: IDRA), up 16.5 percent. Non-cyclical consumer goods & services shares dropped around 0.05 percent in today's trading.
Top 10 US Companies To Buy Right Now: Symantec Corporation(SYMC)
Symantec Corporation provides security, storage, and systems management solutions internationally. The company?s Consumer segment delivers Internet security, PC tune-up, and online backup solutions and services to individual users and home offices. Its Security and Compliance segment provides solutions for endpoint security and management, compliance, messaging management, data loss prevention, encryption, and authentication services to large, medium, and small-sized businesses, as well as offers solutions through its software-as-a-service (SaaS) security offerings. This segment?s products enable customers to secure, provision, and remotely manage their laptops, PCs, mobile devices, and servers. The company?s Storage and Server Management segment provides storage and server management, backup, archiving, and data protection solutions across heterogeneous storage and server platforms, as well as solutions delivered through its SaaS offerings to large, medium, and small-s ized businesses. Symantec?s Services segment offers implementation services and solutions, including consulting, business critical services, education, and managed security services. The company also provides various enterprise support offerings, such as annual maintenance support contracts, including content, upgrades, and technical support. It sells its products through its eCommerce platform, as well as through distributors, direct marketers, Internet-based resellers, system builders, ISPs, and retail locations worldwide. Symantec markets and sells its products through distributors, retailers, direct marketers, Internet-based resellers, original equipment manufacturers, system builders, and Internet service providers; and its e-commerce channels, as well as direct sales force, value-added and large account resellers, and system integrators. The company was founded in 1982 and is headquartered in Mountain View, California.
Advisors' Opinion:- [By Damian Illia]
California-based Symantec Corporation (SYMC) is a company that provides Internet security technology, with a wide range of application and software products of content security solutions and information back-up solutions such as firewall, virtual private network (VPN), virus protection, vulnerability management, intrusion detection and other services, offered to individuals and enterprises. Best known for Norton products which provide antivirus protection, identity protection and online backup, Symantec operates in more than 50 countries, and has recently realigned its business into three divisions: User Productivity & Protection, Information Security and Information Management.
Top 10 US Companies To Buy Right Now: Thermon Group Holdings Inc.(THR)
Thermon Group Holdings, Inc. offers heat tracing solutions for process industries worldwide. The company?s solutions provide an external heat source to pipes, vessels, and instruments for the purposes of freeze protection, temperature and flow maintenance, environmental monitoring, and surface snow and ice melting. Its products comprise a range of electric heat tracing cables, steam tracing components, and tubing bundles. The company also offers instrument and control products, including self-regulating and power limiting heating cables; mineral insulated cables; heat traced tube bundles for environmental gas sampling systems; heat transfer compounds and steam tracers for steam tracing solutions; control and monitoring systems for electric tracing of pipes, tanks, hoppers, and instrument sampling systems; and hopper heating modules. In addition, it provides various turnkey solutions for heat tracing, such as design, front-end optimization, product supply, engineering deli verables, system integration, installation, commissioning, and maintenance services. The company offers its solutions to the energy, chemical processing, power generation, and industrial and commercial infrastructure, as well as engineering, procurement, and construction companies. It serves customers through a network of sales and service professionals, and distributors in approximately 30 countries. The company is headquartered in San Marcos, Texas.
Advisors' Opinion:- [By Seth Jayson]
Thermon Group Holdings (NYSE: THR ) reported earnings on June 5. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q4), Thermon Group Holdings missed estimates on revenues and missed estimates on earnings per share. - [By CRWE]
Thermon Group Holdings, Inc. (NYSE:THR), will issue a press release reporting its fourth quarter and full fiscal 2012 consolidated financial results before the market opens on Friday, June 1 2012.
- [By Namitha Jagadeesh]
ThromboGenics NV (THR) tumbled 18 percent to 22.93 euros, the biggest drop since at least July 2006. The Belgian drugmaker said sales of Jetrea, the eye drug approved by the U.S. last year, will not increase in the second half of the year. That implies full-year sales will be 36 percent less than estimates for 39.4 million euros, according to Richard Vosser, an analyst at JPMorgan Chase & Co. in London.
Top 10 US Companies To Buy Right Now: Salient MLP And Energy Infrastructure Fund (SMF)
Salient MLP and Energy Infrastructure Fund (the Fund), is an organized, non-diversified, closed-end management investment company. Its investment objective is to provide a high level of total return with an emphasis on making quarterly cash distributions (Distributions) to its shareholders. The Fund seeks to provide its shareholders with a tax-efficient vehicle to invest in a portfolio of energy infrastructure companies that own midstream and other energy assets. The Fund will invest at least 80% of its total assets in securities of companies in the Midstream/Energy Sector, consisting of Midstream MLPs, Midstream Companies, Other MLPs and Other Energy Companies. It will invest in equity securities, such as common units, preferred units, subordinated units, general partner interests, common shares, preferred shares and convertible securities in MLPs, Midstream Companies and Other Energy Companies. The Fund is managed by Salient Capital Advisors, LLC. Advisors' Opinion:- [By Eric Lam]
Semafo (SMF) jumped 4.8 percent to C$2.60 and Iamgold gained 2.1 percent to C$4.20 as 21 of 24 members of the S&P/TSX Gold Index increased. Gold rose from a five-month low as investors weighed the outlook for reduced U.S. stimulus as early as next week against speculation physical demand may increase at lower prices. Gold for February delivery advanced 0.6 percent in New York.
Top 10 US Companies To Buy Right Now: Gilead Sciences Inc.(GILD)
Gilead Sciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of life threatening diseases worldwide. Its products include Atripla, Truvada, Viread, Emtriva for the treatment of human immunodeficiency virus infection in adults; Hepsera, an oral formulation for the treatment of chronic hepatitis B; AmBisome, a amphotericin B liposome injection to treat invasive fungal infections; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa for the treatment of chronic angina; Vistide, an antiviral medication for the treatment of cytomegalovirus retinitis in patients with AIDS; and Cayston, an inhaled antibiotic used as a treatment to enhance respiratory systems. The company?s products also comprise Tamiflu, an oral antiviral for the treatment and prevention of influenza A and B; Macugen, an intravitreal injection for the treatment of neovascular a ge-related macular degeneration; and Lexiscan/Rapiscan, an injection used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging. Its products under the Phase III clinical trials consist of Cobicistat, a pharmacoenhancer that is under evaluation as a boosting agent for HIV medicines; Elvitegravir, an oral integrase inhibitor being evaluated as part of combination therapy for HIV; Integrase Single-Tablet, a ?Quad? regimen of elvitegravir, cobicistat, tenofovir disoproxil fumarate, and emtricitabine for the treatment of HIV/AIDS in treatment-naive patients; and Aztreonam for inhalation solution for the treatment of cystic fibrosis patients with Pseudomonas aeruginosa. The company?s Phase II clinical trials products comprise Cicletanine, Ranolazine, and Aztreonam, as well as GS 9190, GS 9256, and GS 9451. Its Phase I clinical trial products include GS 7340, GS 5885, GS 6620, GS 9620, and GS 6624. The company was founded in 1987 and is headquartered in Fost er City, California.
Advisors' Opinion:- [By Ben Levisohn]
Credit Suisse analyst�Ravi Mehrotra�and team raised Celgene to�Outperform from Neutral, putting it on par with Outperform rated Biogen Idec (BIIB) and�Gilead�(GILD) and a notch above Neutral-rated Amgen (AMGN).�
- [By Ben Levisohn]
Still, investors shouldn’t buy the sector willy-nilly. Porges recommends Celgene (CELG) and Gilead (GILD), among large caps, and notes that less-pricey stocks like Amgen (AMGN) should hold up better, as should midcaps with earnings and products, such as Alexion (ALXN).
Top 10 US Companies To Buy Right Now: Diamondcorp PLC (DCP)
DiamondCorp plc is a United Kingdom-based diamond producer. The Company�� 74%-owned Lace diamond mine is located 200 kilometers southwest of Johannesburg in the Free State Province of South Africa. The project comprises the Lace kimberlite. Approximately 33 million tons of kimberlite have been outlined in the main Lace pipe between the 240 meter and the 855 meter level, containing an estimated 13.3 million carats of diamonds at an average estimated grade of 40 carats per hundred tons (cpht). Its subsidiaries include Diamondcorp Holdings Limited, Botswana Diamondcorp Limited, Lace Diamond Mine (Pty) Limited, which is engaged in diamond exploration, Soapstone Investments (Pty) Limited and DCP Exploration (Pty) Ltd. Advisors' Opinion:- [By Aimee Duffy]
Winners
Buckeye Partners (NYSE: BPL ) �trounced analyst expectations on the top and bottom lines, and recorded a distribution coverage ratio of 1.21 times payouts, allowing the partnership to boost its distribution. DCP Midstream Partners' (NYSE: DCP ) �distributable cash flow popped 40% year over year, and the partnership completed its Eagle Ford dropdown transaction with parent company DCP Midstream, boosting its stake in the lucrative South Texas shale play. Boardwalk Energy Partners' (NYSE: BWP ) �operating revenue and net income increased 5% and 10% year over year. More importantly, distributable cash flow popped 24%, though the partnership elected to hold the distribution flat quarter over quarter. Energy Transfer Partners (NYSE: ETP ) �had no distribution increase either, but things are looking better than they have in a while. Production in the Eagle Ford Shale is driving growth at ETP, and the partnership is reorganizing into an operation that is stronger and more diverse than ever before.
Given the current state of U.S. energy production, most midstream companies are winners these days. Kinder Morgan Energy Partners (NYSE: KMP ) got things started off on the right foot, reporting in mid-April and beating expectations on revenue and EPS. Here are some highlights from around the industry:Very strong results here, now let's take a look at some midstream companies that didn't perform as well.
- [By Tyler Crowe]
Perhaps bigger players like Occidental were able to hog the limited takeaway capacity, but this won't be a good reason for slowed production very soon. Magellan Midstream Partners (NYSE: MMP ) and DCP Midstream (NYSE: DCP ) both have pipelines coming on line within the next couple of months that will have takeaway capacity of 225,000 and 350,000 barrels per day, respectively. Once these pipelines come on line, there should be much more room for LINN's production.�
No comments:
Post a Comment